Area of research
Psychiatry and Mental health · Biological Psychiatry
Research interest
Research interests include Schizophrenia research and treatment, Tryptophan and brain disorders, Bipolar Disorder and Treatment, and Forensic Toxicology and Drug Analysis.
Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and “Smart Drug” Use and Misuse
Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study
Substance-Use Disorders and Violence
Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis
Synthetic Cannabinoid use in a Case Series of Patients with Psychosis Presenting to Acute Psychiatric Settings: Clinical Presentation and Management Issues
Globally Efficient Brain Organization and Treatment Response in Psychosis: A Connectomic Study of Gyrification
Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
Substance use, medication adherence and outcome one year following a first episode of psychosis
The brain‐derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia
Inflammation and metabolic changes in first episode psychosis: Preliminary results from a longitudinal study
Brain derived neurotropic factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis
White matter integrity as a predictor of response to treatment in first episode psychosis
Cortical Folding Defects as Markers of Poor Treatment Response in First-Episode Psychosis
Vitamin D deficiency in first episode psychosis: A case–control study
Association Between Symptom Dimensions and Categorical Diagnoses of Psychosis: A Cross-sectional and Longitudinal Investigation
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Sexual dysfunction in people with prodromal or first-episode psychosis